E3 ubiquitin-protein ligase 2 inhibits cell proliferation, migration, and invasion of non-small cell lung cancer through ubiquitination of Notch1-Reference-Cited by-同舟云学术

E3 ubiquitin-protein ligase 2 inhibits cell proliferation, migration, and invasion of non-small cell lung cancer through ubiquitination of Notch1

Published:2022-01 Issue:1 Volume:124 Page:151818
ISSN:0065-1281
Container-title:Acta Histochemica
language:en
Short-container-title:Acta Histochemica

Author:

Guo Yuening,Chi Xiaowen,Qu Si'ying,Sun Yu,Liu Jing,Zhang Lijuan,Cao Caihong,Wang Yansha,Zhang Wei

Publisher

Elsevier BV

Subject

Cell Biology,Histology,General Medicine

Reference32 articles.

1. Notch signaling pathway as a therapeutic target in breast cancer;Al-Hussaini;Mol. Cancer Ther.,2011

2. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma;Allen;Cancer Res.,2011

3. Systemic therapy for locally advanced and metastatic non–small cell lung cancer: a review;Arbour;JAMA J. Am. Med. Assoc.,2019

4. Ectopic expression of E3 ubiquitin-protein ligase 2 in glioma and enhances resistance to apoptosis through activating nuclear factor κ-light-chain-enhancer of B cells;Bai;Oncol. Lett.,2018

5. Xenopus neuralized is a ubiquitin ligase that interacts with XDelta1 and regulates Notch signaling;Deblandre;Dev. Cell,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the contribution of Notch signaling to lung disease development;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-23

2. Notch signaling and targeted therapy in non-small cell lung cancer;Cancer Letters;2024-03

3. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer;Frontiers in Endocrinology;2023-09-19

4. MIB2 promotes the progression of non-small cell lung cancer by regulating cell cycle control pathways;Genes & Genomics;2023-07-12

5. ZEB1-activated Notch1 promotes circulating tumor cell migration and invasion in lung squamous cell carcinoma;Clinical and Translational Oncology;2022-11-23